|
|
Volumn 41, Issue 1, 1999, Pages 72-77
|
|
Biochemical and immunologic mechanisms in atopic dermatitis: New targets for emerging therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 CHLORO 2,4 DINITROBENZENE;
4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE;
ADENYLATE CYCLASE ACTIVATOR;
ASCOMYCIN;
ATIZORAM;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CAFFEINE;
CALCINEURIN;
CLOBETASOL;
CORTICOSTEROID;
CYCLIC AMP;
CYCLOSPORIN;
CYTOKINE;
GAMMA INTERFERON;
HISTAMINE;
HYDROCORTISONE;
IMMUNOGLOBULIN E;
IMMUNOPHILIN;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHOPROTEIN PHOSPHATASE INHIBITOR;
PIMECROLIMUS;
PROSTAGLANDIN E2;
STEROID;
TACROLIMUS;
THEOPHYLLINE;
ASTHMA;
ATOPIC DERMATITIS;
BIOCHEMISTRY;
CELLULAR IMMUNITY;
DENDRITIC CELL;
EOSINOPHIL;
GASTROINTESTINAL TOXICITY;
HUMAN;
IMMEDIATE TYPE HYPERSENSITIVITY;
IMMUNOLOGY;
IMMUNOTHERAPY;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
REVIEW;
THEORY;
TOPICAL DRUG ADMINISTRATION;
|
|
EID: 0032796193
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/S0190-9622(99)70410-X Document Type: Article |
|
Times cited : (87)
|
|
References (49)
|
